Zung Jonathan B. 4
4 · Evelo Biosciences, Inc. · Filed Oct 14, 2022
Insider Transaction Report
Form 4
Zung Jonathan B.
Chief Development Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-07-19+115,000→ 115,000 totalExercise: $2.24Exp: 2032-07-19→ Common Stock (115,000 underlying)
Footnotes (1)
- [F1]The option will vest as to 50% of the underlying shares on the first anniversary of the date of grant, and as to the remaining 50% of the underlying shares on the second anniversary of the date of grant.